Hot Natural Products & Bioactive Compounds

BioCrick offers high-purity natural products and bioactive compounds for scientific research. Our natural product collection includes compounds derived from plants, microorganisms and other biological sources and is widely used in pharmacological, biochemical and drug discovery research.

Natural products remain an important source of bioactive molecules and drug leads. BioCrick provides researchers with high-quality natural product compounds together with catalog numbers, product information and biological activity data.

Hot Products from BioCrick

Showing 8049 - 8056 of 9359 hot products

BioCrick hot natural products and bioactive compounds
Catalog No. Product Name
BCN6816 Poriol
Poriol is a natural product from Cephalotaxus sinensis.
BCN6817 Pilloin
Pilloin exerts a cytotoxic action targeted at the transformed lymphoblasts.
BCN6818 Licoricone
1. Licoricone exhibits anti-helicobacter pylori activity against the CLAR and AMOX-resistant strain as well as four CLAR (AMOX)-sensitive strains.
BCN6819 Isoangustone A
1. Isoangustone A has antitumor activity, it can induce G1 cycle arrest in DU145 human prostate and 4T1 murine mammary cancer cells.
2. Isoangustone A dampens mesangial sclerosis associated with inflammation in response to high glucose through hindering TGF-β and NF-κB signaling.
3. Isoangustone A inhibits cell proliferation by targeting PI3K, MKK4, and MKK7 in human melanoma.
4. Isoangustone A shows strong ferric reducing activities and effectively scavenged DPPH, ABTS(+), and singlet oxygen radicals.
BCN6820 Eucomol
Eucomol is a natural product from Eucomis vandermerwei.
BCN6821 Cirsimarin
1. Cirsimarin exerts potent antilipogenic effect and decreases adipose tissue deposition in mice, it could therefore be a potential candidate for the treatment of obesity.
2. Cirsimarin shows antioxidant activity.
BCN6822 Cirsiliol
1. Cirsiliol shows strong antioxidant activity.
2. Cirsiliol can inhibit TG accumulation in 3T3-L1 preadipocytes, it may have anti-obesity effects.
3. Cirsiliol and rhamnetin can act as promising radiosensitizers that enhance the radiotherapeutic efficacy by inhibiting radiation-induced Notch-1 signaling associated with radioresistance possibly via miR-34a-mediated pathways.
BCN6823 Bonducellin
1. Bonducellin shows weak antiproliferative against A2780 human ovarian cancer cell line , with the IC50 value of 10.6 uM.
2. Bonducellin shows weak antimalarial activity against Plasmodium falciparum with the IC50 value of 26 uM.
3. Bonducellin shows modulation in the MIC of EtBr by eight fold at a concentration of 62.5 mg/L and also shows significant efflux pump inhibitory activity.
4. Bonducellin has anti-inflammatory activities, it can significantly and dose-dependently inhibit the inflammatory mediators; nitric oxide (NO), and cytokines [tumor necrosis factor (TNF)-alpha and interleukin (IL)-12].